Anticoagulation Forum/X
Jun 2, 2025, 08:35
Refining Thrombophilia Testing: New ACE Rapid Resource Offers Practical Guidance for Clinicians – Anticoagulation Forum
The Anticoagulation Forum has released a new ACE Rapid Resource shared on X, offering concise, evidence-based guidance on thrombophilia testing, built on the most current clinical guidelines. This resource supports clinicians across a range of scenarios—from determining the appropriateness of testing to accurately interpreting results.
“Key features include:
Indications for Testing: Defines clinical contexts where thrombophilia testing is justified, helping to prevent overuse and reduce diagnostic errors.
Interpretation Framework: Offers expert-driven explanations on how to interpret test results in the presence of confounding factors such as acute illness, medications, pregnancy, or hormonal therapy.
Clinical Application: Equips healthcare providers with actionable insights to improve diagnostic accuracy and enhance patient outcomes in suspected thrombophilia.
This resource is a collaboration led by Greg Hadlock, PharmD, PhD, with clinical input from Jean Connors, MD, and an expert panel, and is part of a growing library of high-quality tools offered by the Anticoagulation Forum.”
Access the full resource on ACE Rapid Resource – Thrombophilia Testing․
Thrombophilia Testing: Key Insights from the ACE Rapid Resource
The Anticoagulation Forum’s ACE Rapid Resource offers a streamlined, evidence-based summary to guide clinicians on when and how to perform thrombophilia testing. It emphasizes:
- Appropriate indications to avoid unnecessary testing and misinterpretation.
- Result interpretation in the context of confounding factors such as acute illness, medications, and pregnancy.
- Clinical integration to support accurate diagnosis and optimize patient outcomes.
- This resource reflects current best practices and is intended to enhance decision-making in complex thrombotic risk assessments.
Discover the latest expert insights in Hemostasis Today.
-
Jun 7, 2025, 12:35WFH - The New Diagnosis of Hemophilia and Other Bleeding Disorders: A Laboratory Manual
-
Jun 7, 2025, 10:38Help Us Learn More About Hemophilia B - ATHN
-
Jun 7, 2025, 09:44New ICD-10-CM Codes For The Duffy Phenotype Have Recently Been Released - ASH
-
Jun 6, 2025, 17:16The Threshold for Children Receiving Blood Transfusion During Stem Cell Transplants Could Be Safely Reduced - BSH - Haematology
-
Jun 6, 2025, 09:57Cancer treatment and survivorship statistics, 2025 - A Cancer Journal for Clinicians
-
Jun 7, 2025, 10:28IL-10 From Tumoral B Cells Modulates the Diffuse Large B-Cell Lymphoma Microenvironment and Response to Immunotherapy
-
Jun 7, 2025, 08:46David Smadja: A Major Step Forward in The Fight Against Cancer-Related Thrombosis
-
Jun 6, 2025, 15:52Long-term Efficacy and Safety of Mitapivat in Non-Transfusion-Dependent α- or β-thalassaemia - British Journal of Haematology
-
Jun 6, 2025, 10:56Pip Nicolson Highlights Key PITT Case Insight on Anti-PF4 Antibody Testing
-
Jun 3, 2025, 15:30Effects of sickle trait on maternal and perinatal outcomes among pregnant women - Blood Vessels, Thrombosis & Hemostasis
-
Mar 6, 2025, 17:15Olympus Announces Launch of Single-Use Hemostasis Clip
-
Jun 7, 2025, 12:50ASH Sends a Letter to Senate Leaders Urging Them to Reject Harmful Medicaid Changes
-
Jun 7, 2025, 12:41ISTH - Abstracts for ISTH2025 are now LIVE
-
Jun 7, 2025, 12:29ASH - The Future of Classical Hematology is In Excellent Hands
-
Jun 7, 2025, 10:48Join Us For the Bleeding Disorders Conference 2025 - National Bleeding Disorders Foundation
-
Jun 6, 2025, 16:41RFP to Host the Annual EAHAD Congress 2029 is Now Open!
Jun 7, 2025, 12:41
Jun 7, 2025, 12:29
Jun 7, 2025, 10:38